首页> 外国专利> COMBINATION OF BIOENERGY AND NUTRA-EPIGENETIC METABOLIC REGULATORS, NUTRACEUTICAL COMPOUNDS IN CONVENTIONAL AND NANOTECHNOLOGY-BASED COMBINATIONS, FOR REVERSING AND PREVENTING CELLULAR SENESCENCE ACCELERATED BY CHRONIC DAMAGE CAUSED BY DIABETES AND OTHER COMPLEX CHRONIC DEGENERATIVE DISEASES

COMBINATION OF BIOENERGY AND NUTRA-EPIGENETIC METABOLIC REGULATORS, NUTRACEUTICAL COMPOUNDS IN CONVENTIONAL AND NANOTECHNOLOGY-BASED COMBINATIONS, FOR REVERSING AND PREVENTING CELLULAR SENESCENCE ACCELERATED BY CHRONIC DAMAGE CAUSED BY DIABETES AND OTHER COMPLEX CHRONIC DEGENERATIVE DISEASES

机译：生物能和神经抗原代谢调节剂的组合，以常规和基于纳米技术的组合的营养组合物，用于逆转和预防由糖尿病和其他综合症引起的慢性损伤引起的细胞衰老

页面导航

摘要
著录项
相似文献

摘要

The invention elates to compounds of natural origin and their pharmaceutically acceptable and active mixture to decrease glucose, cholesterol, uric acid, and body fat the high levels, cytoprotection of damaged organs, activation of metabolism and cell proliferation. It is exemplified with the pharmaceutical composition comprising a pharmaceutically effective amount of the compounds of Formulation I, and its method on in vitro and in vivo systems. Formulation I and its variables can be used to treat hyperglycemia, gout, dyslipidemia, obesity, insulin resistance, diabetes mellitus, diabetes insipidus, type 1 diabetes, type 2 diabetes, microvascular complications, macrovascular complications, lipid disorders, pre-diabetes, arrhythmias, myocardial infarction, renal and pancreatic complications, cardiovascular complications.

机译：本发明涉及天然来源的化合物及其药学上可接受的活性混合物，以高水平降低葡萄糖，胆固醇，尿酸和人体脂肪，受损器官的细胞保护，代谢激活和细胞增殖。用包含药物有效量的式I化合物的药物组合物及其在体外和体内系统上的方法来举例说明。配方I及其变量可用于治疗高血糖，痛风，血脂异常，肥胖，胰岛素抵抗，糖尿病，尿崩症，1型糖尿病，2型糖尿病，微血管并发症，大血管并发症，脂质紊乱，糖尿病前期，心律不齐，心肌梗塞，肾和胰腺并发症，心血管并发症。

著录项

公开/公告号EP3470060A2

专利类型
公开/公告日2019-04-17

原文格式PDF
申请/专利权人 ASTUDILLO DE LA VEGA HORACIO;
展开▼

申请/专利号EP20170810608
发明设计人 ASTUDILLO DE LA VEGA HORACIO;
展开▼

申请日2017-06-08
分类号A61K9/10;A61K31/05;A61K31/198;A61K47/02;
国家 EP
入库时间 2022-08-21 12:28:01

相似文献

专利
外文文献
中文文献